Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.08 CAD | -.--% | -11.11% | +6.67% |
Business Summary
Number of employees: 11
Sales per Business
CAD in Million | 2021 | Weight | 2022 | Weight | Delta |
---|---|---|---|---|---|
Licensing
45.2
%
| - | - | 0 | 45.2 % | - |
Up-front Fees
29.0
%
| - | - | 0 | 29.0 % | - |
Other Services
25.8
%
| - | - | 0 | 25.8 % | - |
Sales per region
CAD in Million | 2021 | Weight | 2022 | Weight | Delta |
---|---|---|---|---|---|
United States
45.2
%
| - | - | 0 | 45.2 % | - |
Canada
29.0
%
| 0 | nan % | 0 | 29.0 % | - |
Other
25.8
%
| - | - | 0 | 25.8 % | - |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Amina Odidi
FOU | Founder | - | 31/12/97 |
Isa Odidi
CEO | Chief Executive Officer | - | 31/12/97 |
Comptroller/Controller/Auditor | - | 31/03/07 | |
Corporate Officer/Principal | - | 31/01/14 | |
Patrick Yat
PRN | Corporate Officer/Principal | - | 31/12/91 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Norman Betts
BRD | Director/Board Member | 68 | 21/01/19 |
Isa Odidi
CEO | Chief Executive Officer | - | 31/12/97 |
Amina Odidi
FOU | Founder | - | 31/12/97 |
Bahadur Madhani
BRD | Director/Board Member | - | 28/02/06 |
Shawn Graham
BRD | Director/Board Member | - | 30/04/18 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 33,092,665 | 32,511,067 ( 98.24 %) | 0 | 98.24 % |
Holdings
Name | Equities | % | Valuation |
---|---|---|---|
GROWLIFE, INC. 10.84% | 3,662,761 | 10.84% | 7,326 $ |
Company contact information
Intellipharmaceutics International, Inc.
30 Worcester Road
M9W 5X2, Toronto
+416 798 3001
http://www.intellipharmaceutics.comSector
Sales per Business
Sales per region
1st Jan change | Capi. | |
---|---|---|
+6.67% | 1.93M | |
+32.36% | 695B | |
+26.51% | 568B | |
-4.40% | 361B | |
+19.46% | 330B | |
+3.50% | 283B | |
+16.34% | 239B | |
+6.68% | 204B | |
-9.08% | 198B | |
+8.62% | 168B |
- Stock Market
- Equities
- IPCI.H Stock
- Company Intellipharmaceutics International Inc.